People channel feed – Endpoints News

People channel feed

Cue Biopharma prioritizes autoimmune pipeline, axes a quarter of staff to save cash

10 months ago

Manatt scoops up health tech experts Christina Farr and Tom Cassels

10 months ago

Exclusive: After selling Mirati to BMS for nearly $5B, Chuck Baum lands at another ‘undruggable’ company

10 months ago

Bob Langer, Flagship's Stephen Berenson to depart Moderna's board as Carlyle co-founder joins

10 months ago

Sino Biopharm's invoX to restructure, likely cutting about 60 roles

10 months ago

Layoffs at Rapt Therapeutics after winding down mid-stage trials of lead drug

10 months ago

Nadir Mahmood returns to Nkarta a year after leaving; BeiGene picks longtime Merck exec for CFO post

10 months ago

Gilead chief medical officer Merdad Parsey to leave company early next year

10 months ago

Cassava founder and CEO resigns as federal probes progress

10 months ago

Caribou to slash preclinical allogeneic CAR-NK work, lay off 12% of staff

10 months ago

Metagenomi science chief departs, just a few months after IPO

10 months ago

Mikael Dolsten isn’t the only one moving on from Pfizer; Lilly names interim finance chief

10 months ago

Roche's gene therapy biotech Spark is laying off employees, ending some early-stage programs

10 months ago

JPM’s life sciences VC team is growing

10 months ago

Ten biotech executives who reaped the biggest M&A windfalls, netting $40M+ exit packages

10 months ago

Novartis to shut down San Diego technical research and development facility

10 months ago

AbbVie CSO Tom Hudson to retire, replaced by medical chief

10 months ago

The best-paying biotechs in the Bay Area, Boston and San Diego for 2023

10 months ago

How the world's biggest pharma and biotech companies paid their typical worker in 2023

10 months ago

Who pays the most (and least) in biopharma? We analyzed median pay at 177 companies

10 months ago

Biopharma’s 20 highest-paid CEOs of 2023, earning $20M+ pay packages

10 months ago

Pfizer CSO Mikael Dolsten to depart after 15 years leading drug giant's R&D

10 months ago

Apollomics plans to lay off staff, narrow focus for lung cancer trial

10 months ago

Following a pivotal trial fail and layoffs, Ovid finds itself in a familiar spot

10 months ago

First page Previous page 8 9 101112 13 14 Next page Last page